Clinical Trials Browser

Phase 2 × INDUSTRY × Advanced Non-Small Cell Lung Carcinoma × Clear all

NCT03430063 2022-11-03

A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer

Phase 2 Terminated

28 enrolled 16 charts

Advanced Non-Small Cell Lung Carcinoma